Long-term result of a multicenter clinical study of cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC).
机构：[1]Cancer Center, Sun Yat-sen University, Guangzhou, China[2]Sun Yat-Sen University Cancer Center, Guangzhou, China[3]Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China[4]Sichuan Cancer Hospital, Chengdu, China四川省肿瘤医院[5]Fujian Cancer Hospital, Fuzhou, China[6]Fudan University Cancer Center, Shanghai, China[7]Guizhou Cancer Hospital, Guiyang, China[8]The First Affiliated Hospital of Guangxi Medical University, Nanning, China[9]Zhongnan Hosp Wuhan Univ, Wuhan, HUBEI, China[10]Cancer Ctr Sun Yat Sen Univ, Guangzhou, China
Chen Chun-yan,Zhao Chong,Gao Li,et al.Long-term result of a multicenter clinical study of cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC).[J].JOURNAL OF CLINICAL ONCOLOGY.2015,33(15):doi:10.1200/jco.2015.33.15_suppl.e17020.
APA：
Chen, Chun-yan,Zhao, Chong,Gao, Li,Lang, Jin-yi,Pan, Jian-ji...&Lu, Tai-xiang.(2015).Long-term result of a multicenter clinical study of cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC)..JOURNAL OF CLINICAL ONCOLOGY,33,(15)
MLA：
Chen, Chun-yan,et al."Long-term result of a multicenter clinical study of cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC).".JOURNAL OF CLINICAL ONCOLOGY 33..15(2015)
医学